GENVOYA(elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide)tablets(三十三)
irus (HBV) infection and take GENVOYA, your HBV may get worse (flare-up) if you stop taking GENVOYA. A "flare-up" is when your HBV infection suddenly returns in a worse way than before.
It is not known if GENVOYA is safe and effective in people who have both HIV-1 and HBV infection.
Do not run out of GENVOYA. Refill your prescription or talk to your healthcare provider before your GENVOYA is all gone.
Do not stop taking GENVOYA without first talking to your healthcare provider.
If you stop taking GENVOYA, your healthcare provider will need to check your health often and do blood tests regularly for several months to check your HBV infection. Tell your healthcare provider about any new or unusual symptoms you may have after you stop taking GENVOYA.
For more information about side effects, see the section "WHAT ARE THE POSSIBLE SIDE EFFECTS OF GENVOYA?"
What is GENVOYA?
GENVOYA is a prescription medicine that is used without other antiviral medicines to treat Human Immunodeficiency Virus-1 (HIV-1) in people 12 years of age and older:
who have not received anti-HIV-1 medicines in the past, or
to replace their current anti-HIV-1 medicines for people whose healthcare provider determines that they meet certain requirements.
HIV-1 is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).
GENVOYA contains the prescription medicines elvitegravir (VITEKTA®), cobicistat (TYBOST®), emtricitabine (EMTRIVA®) and tenofovir alafenamide.
It is not known if GENVOYA is safe and effective in children under 12 years of age or who weigh less than 77 lbs.
Do not take GENVOYA if you also take a medicine that contains:
alfuzosin hydrochloride (UROXATRAL®)
carbamazepine (CARBATROL®, EPITOL®, EQUETRO®, TEGRETOL®, TEGRETOL-XR®, TERIL®)
cisapride (PROPULSID®, PROPULSID QUICKSOLV®)
ergot-containing medicines, including:
dihydroergotamine mesylate (D.H.E. 45®, MIGRANAL®)
ergotamine tartrate (CAFERGOT®, MIGERGOT®, ERGOSTAT®, MEDIHALER ERGOTAMINE®, WIGRAINE®, WIGRETTES®)
methylergonovine maleate (ERGOTRATE®, METHERGINE®)
lovastatin (ADVICOR®, ALTOPREV®, MEVACOR®)
lurasidone (LATUDA®)
midazolam, when taken by mouth
phenobarbital (LUMINAL®)
phenytoin (DILANTIN®, PHENYTEK®)
pimozide (ORAP®)
rifampin (RIFADIN®, RIFAMATE®, RIFATER®, RIMACTANE®)
sildenafil (REVATIO®), when used for treating the lung problem, pulmonary arterial hypertension (PAH)
simvastatin (SIMCOR®, VYTORIN®, ZOCOR®)
triazolam (HALCION®)
St. John's wort (Hypericum perforatum) or a product that contains St. John's wort
What should I tell my healthcare provider before taking GENVOYA?
Before taking GENVOYA, tell your healthcare provider if you:
have liver problems, including hepatitis B infection
have kidney problems
have any other medical conditions
are pregnant or plan to become pregnant. It is not known if GENVOYA can harm your unborn baby. Tell your healthcare provider if you become pregnant while taking GENVOYA.
Pregnancy Registry: There is a pregnancy registry for women who take antiviral medicines during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk with your healthcare provider about how you ca |
